[{"Assets_0_Q3_USD":1049059000.0,"CommonStockSharesOutstanding_0_Q3_shares":589772330.0,"EarningsPerShareBasic_1_Q3_USD":0.21,"EarningsPerShareBasic_3_Q3_USD":0.01,"EarningsPerShareDiluted_1_Q3_USD":0.2,"EarningsPerShareDiluted_3_Q3_USD":0.01,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-80997000.0,"NetIncomeLoss_1_Q3_USD":117386000.0,"NetIncomeLoss_3_Q3_USD":6218000.0,"StockholdersEquity_0_Q3_USD":750140000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":600612680.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":561237818.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":547546656.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":527329985.0,"Ticker":"BGNE","CIK":"1651308","name":"BEIGENE, LTD.","OfficialName":"BeiGene Ltd. American Depositary Shares","form":"10-Q","period":"20170930","fy":"2017.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"18163188203.0","Country":"Cayman Islands","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20171113"}]